VRXA Expands R&D Hub
VERAXA Biotech expands its R&D hub in Heidelberg, increasing laboratory space by over 60% to accelerate clinical development of its BiTAC-TCE and ADC programs
VRXA - VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical DevelopmentGreater than 60% increase in laboratory space will strengthen R&D capabilities, facilitate acceleration toward clinical development, and increase ability to tap into Heidelberg's world-class medical oncology environment